KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) FCF Margin (2016 - 2025)

Historic FCF Margin for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to 8.92%.

  • NovoCure's FCF Margin rose 91200.0% to 8.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.15%, marking a year-over-year increase of 33900.0%. This contributed to the annual value of 11.44% for FY2024, which is 82800.0% up from last year.
  • According to the latest figures from Q3 2025, NovoCure's FCF Margin is 8.92%, which was up 91200.0% from 13.49% recorded in Q2 2025.
  • Over the past 5 years, NovoCure's FCF Margin peaked at 17.64% during Q2 2021, and registered a low of 31.3% during Q1 2024.
  • In the last 5 years, NovoCure's FCF Margin had a median value of 7.68% in 2024 and averaged 5.84%.
  • As far as peak fluctuations go, NovoCure's FCF Margin tumbled by -336300bps in 2023, and later skyrocketed by 206700bps in 2024.
  • Over the past 5 years, NovoCure's FCF Margin (Quarter) stood at 0.1% in 2021, then tumbled by -8189bps to 7.89% in 2022, then plummeted by -102bps to 15.98% in 2023, then skyrocketed by 52bps to 7.68% in 2024, then soared by 216bps to 8.92% in 2025.
  • Its FCF Margin was 8.92% in Q3 2025, compared to 13.49% in Q2 2025 and 29.86% in Q1 2025.